Announcements Trials

Browse Landscape

Phase

Phase 1/2 3 Phase 1 3 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 239 Carcinoma, Non-Small-Cell Lung 237 Prostatic Neoplasms 172 Multiple Myeloma 154 Neoplasms 136 Colorectal Neoplasms 127 Leukemia, Myeloid, Acute 123 Lung Neoplasms 110 Neoplasm Metastasis 101 Squamous Cell Carcinoma of Head and Neck 94 Carcinoma, Hepatocellular 91 Melanoma 89 Lymphoma 85 Triple Negative Breast Neoplasms 77 Pancreatic Neoplasms 77 Ovarian Neoplasms 72 Sarcoma 71 Carcinoma, Renal Cell 66 Brain Neoplasms 66 Lymphoma, Large B-Cell, Diffuse 65 Recurrence 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Head and Neck Neoplasms 57 Lymphoma, Non-Hodgkin 56 Leukemia, Lymphocytic, Chronic, B-Cell 55 Stomach Neoplasms 54 Hematologic Neoplasms 53 Endometrial Neoplasms 53 Urinary Bladder Neoplasms 51 Small Cell Lung Carcinoma 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenoviridae Infections × 90 days × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡